Similarly, another study revealed that CMSS1, an RBP-related gene, is markedly upregulated in non-small cell lung cancer (NSCLC) tissues, with its high expression levels closely linked to unfavorable clinical outcomes in NSCLC patients [38]. Here, CMSS1 is linked to non-small cell lung carcinoma.